|
Home
[Viewing Options]

Journal Articles, 2001

  • Aubert G, Hassan-Walker AF, Madrigal JA, Emery VC, Morte C, Grace S, Koh MB, Potter M, Prentice HG, Dodi A, Travers PJ : Cytomegalovirus-Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants. J infect Disease, 184, 955-964, 2001.

  • Barber LD, Howarth M, Bowness P, Elliott T : The quantity of naturally processed peptides stably bound by HLA-A*0201 is significantly reduced in the absence of tapasin. Tissue Antigens, 58, 363-368, 2001.

  • Clark RE, Dodi IA, Hill SC, Lill JR, Aubert G, Macintyre AR, Rojas J, Bourdon A, Bonner PLR, Wang L, Christmas SE, Travers PJ, Creaser CS, Rees RC, Madrigal JA : Direct evidence that leukaemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein Blood, 98, 2887, 2001.

  • Creaser CS, Lill JR, Bonner PLR, Hill SC, Rees RC Christmas SC,Clark R, Norbury L, Dodi IA, Madrigal JA : Characterisation of HLA-A3 restricted peptide from the BCR-ABL fusion protein of the Philadelphia Chromosome using Nano-electrospray ion trap mass spectrometry. Advances in Mass Spectrometry, 15, 637-639, 2001.

  • Little A-M, Scott I, Peso S, Marsh SGE, Argüello JR, Cox ST, Ramon D, Vullo C, Madrigal JA : HLA Class I diversity in Kolla Amerindians. Human Immunology, 62, 170-179, 2001.

  • Marsh SGE, Bodmer JG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, Hansen JA, Mach B, Mayr WR, Parham, P, Petersdorf EW, Sasazuki T, Schreuder GMTh, Strominger JL, Svejgaard A, Terasaki PI : Nomenclature for factors of the HLA system, 2000
    Tissue Antigens, 57, 236-283, 2001
    Human Immunology, 62, 419-468, 2001
    European Journal of Immunogenetics, 28, 377-424, 2001
    download now
  • Marsh SGE, Robinson J : The IMGT/HLA Sequence Database, Reviews in Immunogenetics, 2, 518-531, 2001.

  • Orleans-Lindsay JK, Barber LD, Prentice HG, Lowdell MW : Acute myeloid leukaemia cells secrete a soluble factor that inhibits T and NK cell proliferation but not cytolytic function - implications for the adoptive immunotherapy of leukaemia. Clinical and Experimental Immunology, 126, 403-411, 2001.

  • Robinson J, Pérez-Rodríguez M, Waller MJ, Cuillerier B, Bahram S, Yao Z, Albert ED, Madrigal JA, Marsh SGE : MICA Sequences 2000. Immunogenetics, 53, 150-169, 2001.

  • Robinson J, Waller MJ, Parham P, Bodmer JG, Marsh SGE : IMGT/HLA Database - a sequence database for the Human Major Histocompatibility Complex. Nucleic Acid Research, 29, 210-213, 2001.

  • Rosette C, Werlen G, Daniels MA, Holman PO, Alam SM, Travers PJ, Gascoigne NR, Palmer E, Jameson SC : The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. Immunity, 15, 59-70, 2001.

  • Schreuder GMTh, Hurley CK, Marsh SGE, Lau M, Maiers M, Kollman C, Noreen HJ : The HLA Dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens.
    Tissue Antigens, 58, 109-140, 2001
    Human Immunology, 62, 826-849, 2001
    European Journal of Immunogenetics, 28, 565-596, 2001
  • Szmania S, Galloway A, Bruorton M, Musk P, Aubert G, Dodi A, Arthur A, Pyle H, Hensel N, Ta N, Lamb L, Madrigal A, Barrett J, Henslee-Downey J, van Rhee F : Isolation and Expansion of Cytomegalovirus-Specific Cytotoxic T Lymphocytes to Clinical Scale From A Single Blood Draw Using Dendritic Cells and HLA-Tetramers Blood, 98, 505, 2001.

  • Ulrich S, Helmberg W, Wagner T, Corell A, Marsh SGE, Lanzer G : A novel HLA-DRB1 sequence, DRB1*11272. Tissue Antigens, 57, 175-176, 2001.

  • Vorechovsky I, Kralovicova J, Laycock MD, Webster ADB, Marsh SGE, Madrigal A, Hammarström L : Stability of short tandem repeats between the RING3 and HLA-B loci on the A1, B8, DRB1*03 haplotypes: a recent ancestral diversification in the region of the highest GC content in the HLA. European Journal of Human Genetics, 9, 590-598, 2001.